Etiquetas
phase 1 designs
candidate screening
drug development
ind
preclinical
proof of concept
maximum tolerated dose
target identification
target validation
phase 3
phase 2
phase 1
lead development
nda
drug discovery
drug research
designs
regulatory
hts
scales used for checking homogenity
test for homogenity
assumption for model
bucher method
indirect comparisons
heterogenity
software
model
random model
nma
direct comparison
cochrane
node splitting
consistency
test for heterogenity
fixed model
mixed comparisons
inconsistency
bias
homogenity
Ver más
Etiquetas
phase 1 designs
candidate screening
drug development
ind
preclinical
proof of concept
maximum tolerated dose
target identification
target validation
phase 3
phase 2
phase 1
lead development
nda
drug discovery
drug research
designs
regulatory
hts
scales used for checking homogenity
test for homogenity
assumption for model
bucher method
indirect comparisons
heterogenity
software
model
random model
nma
direct comparison
cochrane
node splitting
consistency
test for heterogenity
fixed model
mixed comparisons
inconsistency
bias
homogenity
Ver más